Respiratory Syncytial Virus and Premature Infants Born at 32 Weeks' Gestation or Earlier

Article Abstract:

Prophylactic treatment of premature infants born at 32 weeks or earlier to prevent respiratory syncytial virus (RSV) would be cost effective and save infant lives and sickness. With approval by the FDA of two drugs which provide a passive immunity, that is possible, although difficulties in cost and administration were such that the American Academy of Pediatrics felt compelled to issue risk-stratified guidelines for the use of them. The two drugs are Respigam which lowered risk of hospitalization from 41% to 63% in high-risk infants, and Palivizumab whichh lowered the risk by 55%.

Health aspects, Prevention, Drug therapy, Respiratory syncytial virus, Neonatal intensive care, Respigam (Medication)

---

Lipid Intolerance in Neonates Receiving Dexamethasone for Bronchopulmonary Dysplasia

Article Abstract:

The corticosteroid dexamethasone may raise blood levels of a class of fats called triglycerides as well as levels of free fatty acids (FFA). Many premature babies need intravenous fats as a nutritional supplement after they are born. They may also need corticosteroids to prevent a complication of premature birth called bronchopulmonary dysplasia, which is a lung disease. In a study of 10 premature newborn babies who were receiving intravenous fats and dexamethasone to prevent bronchopulmonary dysplasia, six developed high blood levels of triglycerides and FFA.

Causes of, Complications and side effects, Physiological aspects, Infants (Premature), Premature infants, Hyperlipidemia, Dexamethasone

---

How Commonly Are Children Hospitalized for Dehydration Eligible for Care in Alternative Settings?

Article Abstract:

Many children who are hospitalized for dehydration could be discharged to a short-stay treatment unit or even to their home for home nursing once the condition has been treated. In a study of 1,121 children hospitalized for dehydration, only 27% had a serious underlying problem. The rest had minimal dehydration and 95% were successfully treated within 24 hours. But many remained in the hospital longer than that. Eighty-six percent of the average hospital stay occurred after the child was successfully treated.

Care and treatment, Children, Hospitalization, Dehydration (Physiology)

Similar abstracts:

• Abstracts: Respiratory diseases and allergies in two polluted areas in East Germany. The effect of ambient carbon monoxide on low birth weight among children born in Southern California between 1989 and 1993
• Abstracts: Preventing Surgical Infection Is More Important Than Ever. Experts sort out headache classification, new guidelines for physicians to debut
• Abstracts: Advance directives on admission: clinical implications and analysis of the Patient Self-Determination Act of 1990
• Abstracts: Are we ready for clinical gene therapy? Placing health promotion into the context of our lives. Health promotion made easy -- give a gift!
• Abstracts: Clinical preventive services efficacy and adolescents' risky behaviors. Parents' Utilities for Outcomes of Occult Bacteremia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.